We Conduct First-Class Clinical Trials That Deliver New Therapies, Devices And Diagnostics With Tangible Impacts For People The World Over
Adults who have a diagnosis of severe alopecia areata (AA) may qualify for this clinical research trial and receive investigational subcutaneous injection or placebo.
Age: ≥18 years old
AA diagnosis ≥ 1 year
50% or more scalp hair loss
Current AA episode: ≥ 6 months and ≤ 8 years
Willing to maintain hair style and hair care such as products, wigs, and extensions. Unable to shave scalp hair 2 weeks before visits.
Patients will be asked to visit the clinic about 12 times over approximately 54 weeks. There is no cost to participate, and participants will be reimbursed for their time and travel.
For further information on the study, please follow the link:
